Neurol. praxi. 2020;21(1):50-52 | DOI: 10.36290/neu.2020.026

Alpha-lipoic acid and neuropatic pain

MUDr. Pavlína Nosková, Ph.D.
CLB KARIM VFN a 1. LF UK Praha

Alpha-lipoic acid, a potent antioxidant, has been associated with support treatment for symptomatic diabetic neuropathy in several clinical trials. In the other indications is a subject for further research.

Keywords: alfa-lipoic acid, diabetic neuropathy.

Published: March 30, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P. Alpha-lipoic acid and neuropatic pain. Neurol. praxi. 2020;21(1):50-52. doi: 10.36290/neu.2020.026.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D, SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26(3): 770-776. Go to original source...
    2. Baicus C, Purcarea A,von Elm E, Delcea C, Furtunescu FL. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews 2018; 2. https://doi.org//10.1002/14651858.CD012967. Go to original source...
    3. Bednařík J. Ambler Z. Léčba diabetické neuropatie. Neurol. praxi 2012; 13(Suppl. E): 25-30.
    4. Bednařík J, Ambler Z, Opavský J, Keller O, Rokyta R, Mazanec R, Lejčko J, Kozák J, Suchý M, Pátá M, Kožený P. Klinický standard pro farmakoterapii neuropatické bolesti. Cesk Slov Neurol N 2012; 75/108(1): 93-101.
    5. Bruce RD, Merlin J, Lum, PJ, Ahmed E, Alexander C, Corbett AH, Foley K, Leonard K, Treisman GJ, Selwyn P. HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus. Clin Infect Dis 2017; 65(10): 1601-1606. Go to original source... Go to PubMed...
    6. Cruccu G, Truini A. A review of neuropathic pain: from guidelines to clinical practise. Pain Ther 2017; 6(Suppl. 1): 35-42. Go to original source...
    7. Edelsberger T. in Diabetická neuropatie. Maxdorf 2008. Praha: 22-25.
    8. Feldmann EL, McCulloch DK. Treatment of diabetic neuropathy. www.uptodate.com 2018. https://www.uptodate.com/contents/treatment-of-diabetic-neuropathy?search=diabetic%20neuropathy%20treatment&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1, navštíveno 19. 1. 2019.
    9. Fricová J, Hakl M. Farmakoterapie nenádorové průlomové bolesti. Metodické pokyny pro farmakoterapii bolesti - speciální část. Bolest 2017; 20(Suppl. 1): 7.
    10. Gomes MB, Negrato CA. Alpha-lipoic acid as pleiotropic compound with potential therapeutic use in diabetes and other chronic disease. Diabetol Metab Syndr 2014; 6(1): 80. https://dmsjournal.biomedcentral.com/track/pdf/10.1186/1758-5996-6-80. Go to original source...
    11. Guo Y, Jones D, Pamer JL. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. Support Care Cancer 2014; 22: 1223. Go to original source... Go to PubMed...
    12. Lacigová S, Rušavý Z, Jirkovská A, Škrha J. Doporučený postup diagnostiky a léčby diabetické neuropatie. Diabetologie, metabolismus, endokrinologie, výživa 2016; 19(2): 57-63.
    13. Lejčko J, Kozák J, Fricová J, Sláma O, Hakl M, Gabrhelík T. Metodické pokyny pro farmakoterapii bolesti. Bolest 2016; 19(suppl. 1).
    14. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid for symptomatic neuropathy in patients with diabetes. A meta-analysis of randomized controlled trials. Int J Endocrinol 2012; 2012: 45627. Go to original source...
    15. Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 1999; 31(3): 171-179. Go to original source... Go to PubMed...
    16. SPC Thioctacid 600 mg inj sol. http://www.sukl.cz/modules/medication/detail.php?code=0231890&tab=texts, navštíveno 19. 1. 2019.
    17. SPC Thioctacid 600 mg tbl flm http://www.sukl.cz/modules/medication/detail.php?code=0231890&tab=texts, navštíveno 19. 1. 2019.
    18. Vondrová H. Léčba diabetické polyneuropatie. Neurol. praxi 2008; 9(4): 245-251.
    19. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29(11): 2365-2370. Go to original source...
    20. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, Kerum G, Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22(8): 1296-1301. Go to original source...
    21. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, Gries FA. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38(12): 1425-1433. Go to original source...
    22. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schütte K, Dyck PJ. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011; 34(9): 2054-2060. Go to original source...
    23. Ziegler D, Keller J, Maier Ch, Panek J. Diabetische Neuropathie. Diabetologie und Stoffwechsel. 2019; 14(Suppl 2): 243-257. Go to original source...
    24. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21(2): 114-121. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.